Tumor-infiltrating lymphocytes (TIL) are primarily composed of CD8+ CTLs, conventional CD4+ T helper cells and regulatory T cells (Tregs), which in most studies are defined by CD4+ CD25+ FoxP3+ expression (4–6). The gene discussed is CD8A; the disease is neoplasm.